Isotretinoin safety requirements — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Do not supply until pregnancy prevention and safety requirements are resolved with the prescriber
Isotretinoin is highly teratogenic and is subject to strict risk minimisation measures, including pregnancy prevention requirements where relevant. Missed monitoring and low mood both require prescriber review before supply. St John's wort may interact with hormonal contraception and is not appropriate casual advice here. Patient access should be balanced with the mandated safety framework.
Reference: BNF; MHRA Drug Safety Update